Rochaix L - Search Results

1

HTA agencies facing model biases: the case of type 2 diabetes.

Raimond V, Josselin JM, Rochaix L. Raimond V, et al. Among authors: rochaix l. Pharmacoeconomics. 2014 Sep;32(9):825-39. doi: 10.1007/s40273-014-0172-8. Pharmacoeconomics. 2014. PMID: 24862533 Review.

2

National Authority for Health: France.

Rochaix L, Xerri B. Rochaix L, et al. Issue Brief (Commonw Fund). 2009 Jul;58:1-9. Issue Brief (Commonw Fund). 2009. PMID: 19639712

3

[Economic evaluation of health networks: why and how?].

Rochaix L. Rochaix L. Nephrol Ther. 2009 Jun;5 Suppl 4:S256-60. doi: 10.1016/S1769-7255(09)74555-9. Nephrol Ther. 2009. PMID: 19596345 French.

4

Comparative effectiveness research and evidence-based health policy: experience from four countries.

Chalkidou K, Tunis S, Lopert R, Rochaix L, Sawicki PT, Nasser M, Xerri B. Chalkidou K, et al. Among authors: rochaix l. Milbank Q. 2009 Jun;87(2):339-67. doi: 10.1111/j.1468-0009.2009.00560.x. Milbank Q. 2009. PMID: 19523121 Free PMC article.

5

[French Health Authority guide].

Bouvenot G, Dubernard JM, Rochaix L. Bouvenot G, et al. Among authors: rochaix l. Therapie. 2012 Sep-Oct;67(5):407. doi: 10.2515/therapie/2012053. Epub 2012 Dec 18. Therapie. 2012. PMID: 23241249 Free article. French. No abstract available.

6

Medico-economic evaluation of health products in the context of the Social Security Financing Act for 2012.

Dervaux B, Baseilhac E, Fagon JY; participants of round table N°6 of Giens Workshops XXVIII (th); Ameye V, Angot P, Audry A, Becquemont L, Borel T, Cazeneuve B, Courtois J, Detournay B, Favre P, Granger M, Josseran A, Lassale C, Louvet O, Pinson J, de Pouvourville G, Rochaix L, Rumeau-Pichon C, de Saab R, Schwarzinger M, Sun A. Dervaux B, et al. Among authors: rochaix l. Therapie. 2013 Jul-Aug;68(4):253-63. doi: 10.2515/therapie/2013045. Epub 2013 Aug 28. Therapie. 2013. PMID: 23981264 Free article. English, French.

7

[Analysis of the health care market: which role for health economics?].

Rochaix L. Rochaix L. Rev Epidemiol Sante Publique. 1996 Nov;44(6):498-510. Rev Epidemiol Sante Publique. 1996. PMID: 9005486 French.

8

COST-EFFECTIVENESS OF INTERVENTIONS BASED ON PHYSICAL ACTIVITY IN THE TREATMENT OF CHRONIC CONDITIONS: A SYSTEMATIC LITERATURE REVIEW.

Guillon M, Rochaix L, Dupont JK. Guillon M, et al. Among authors: rochaix l. Int J Technol Assess Health Care. 2018 Jan;34(5):481-497. doi: 10.1017/S0266462318000533. Epub 2018 Oct 9. Int J Technol Assess Health Care. 2018. PMID: 30296954

9

State autonomy, policy paralysis: paradoxes of institutions and culture in the French health care system.

Rochaix L, Wilsford D. Rochaix L, et al. J Health Polit Policy Law. 2005 Feb-Apr;30(1-2):97-119. doi: 10.1215/03616878-30-1-2-97. J Health Polit Policy Law. 2005. PMID: 15943389

10

Delivering generics without regulatory incentives? Empirical evidence from French general practitioners about willingness to prescribe international non-proprietary names.

Paraponaris A, Verger P, Desquins B, Villani P, Bouvenot G, Rochaix L, Gourheux JC, Moatti JP; Panel MG Paca. Paraponaris A, et al. Among authors: rochaix l. Health Policy. 2004 Oct;70(1):23-32. doi: 10.1016/j.healthpol.2004.01.008. Health Policy. 2004. PMID: 15312707

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

34 results

Search Page